Pilotstudy; The use of Gelclair film in children undergoing chemo and/or radiotherapy to prevent oral mucositis and improve quality of life.

Pilotstudy; The use of Gelclair film in children undergoing chemo and/or radiotherapy to prevent oral mucositis and improve quality of life. - Gelclair use in pediatric oncology patients.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON31933

Enrollment

Registered

2008-08-07

Start date

2008-03-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pijn pain sore mouth

Interventions

3x day rinse with Gelclair

Eligibility

Age

2 Years to 17 Years

Inclusion criteria

Inclusion criteria: oncology patients aged 0-18 years registered with the IHOBA mucositis grade 1-4 (WHO) chemotherapy +/or radiotherapy treatment written infromed consent

Exclusion criteria

Exclusion criteria: non fluent Dutch speaking parents in the outpatient setting known allergy for gelclair

Design outcomes

Primary

Measure	Time frame
Pain score WHO gradation of oral mucositis	—

Secondary

Measure	Time frame
days in hospital related to oral mucositis weight loss Enteral or parentral feeding related to oral mucositis Number of times gelclair is applied/rinsed per day (compliance)	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)